Schedule 13D ownership disclosure
HOOKIPA PHARMA INC
Common Stock, par value $0.0001 per share · CUSIP: 43906K209
Event date: 2025-02-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sofinnova Capital VI FCPRReported CIK 0001441261
Shares: 314,259.00 · Class: 2.6%
- Sofinnova Partners SASReported CIK 0001574139
Shares: 314,259.00 · Class: 2.6%
- Antoine PapiernikReported CIK 0001768408
Shares: 314,259.00 · Class: 2.6%
- Henrijette Richter
Shares: 314,259.00 · Class: 2.6%
- Maina BhamanReported CIK 0001901013
Shares: 314,259.00 · Class: 2.6%
- Graziano SeghezziReported CIK 0001573749
Shares: 314,259.00 · Class: 2.6%
- Anta Gkelou
Shares: 314,259.00 · Class: 2.6%
- Karl Naegler
Shares: 314,259.00 · Class: 2.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-014167
- Form type
- SCHEDULE 13D/A
- Filer
- HOOKIPA Pharma Inc.
- CIK
- CIK 1760542
- Filed
- Feb 14, 2025
- Reporting period
- Feb 14, 2025
- Description
- Schedule 13D beneficial ownership